Volume 144, Issue 1, Pages (January 2013)

Slides:



Advertisements
Similar presentations
Volume 136, Issue 4, Pages (April 2009)
Advertisements

Ras Activity Levels Control the Development of Pancreatic Diseases
Volume 119, Issue 5, Pages (November 2000)
Pharmacologic Inhibition of IκB Kinase Activates Immediate Hypersensitivity Reactions in Mice  Dai Miyazaki, Sachiko Mihara, Koudai Inata, Shin-ichi Sasaki,
Induction of Apoptosis by Crambene Protects Mice against Acute Pancreatitis via Anti- Inflammatory Pathways  Yang Cao, Sharmila Adhikari, Marie Véronique.
Volume 78, Issue 3, Pages (August 2010)
Volume 145, Issue 6, Pages (December 2013)
Volume 131, Issue 3, Pages (September 2006)
Volume 151, Issue 6, Pages (December 2016)
Volume 143, Issue 2, Pages (August 2012)
Constitutive and tumor necrosis factor-α-induced activation of nuclear factor-κB in adenomyosis and its inhibition by andrographolide  Bin Li, M.S., Ming.
Volume 66, Issue 3, Pages (September 2004)
The Protective Effects of Melittin on Propionibacterium acnes–Induced Inflammatory Responses In Vitro and In Vivo  Woo-Ram Lee, Kyung-Hyun Kim, Hyun-Jin.
Aryl Hydrocarbon Receptor Regulates Pancreatic IL-22 Production and Protects Mice From Acute Pancreatitis  Jing Xue, David T.C. Nguyen, Aida Habtezion 
Volume 143, Issue 5, Pages e4 (November 2012)
Volume 85, Issue 2, Pages (January 2014)
Prolyl Hydroxylase-3 Is Down-regulated in Colorectal Cancer Cells and Inhibits IKKβ Independent of Hydroxylase Activity  Jing Xue, Xuebing Li, Shi Jiao,
Volume 37, Issue 2, Pages (August 2012)
Ilya Gukovsky, Anna Gukovskaya  Gastroenterology 
Volume 133, Issue 6, Pages (December 2007)
Volume 123, Issue 4, Pages (October 2002)
Volume 136, Issue 4, Pages (April 2009)
Volume 137, Issue 4, Pages e5 (October 2009)
Ganesan Ramesh, W. Brian Reeves  Kidney International 
Xian-Hua Lin, M. D. , Miao-E. Liu, M. B. , Hai-Yan Xu, M. B
Volume 144, Issue 1, Pages (January 2013)
Volume 127, Issue 1, Pages (July 2004)
Volume 119, Issue 5, Pages (November 2000)
Volume 149, Issue 7, Pages (December 2015)
Volume 134, Issue 1, Pages e1 (January 2008)
Volume 88, Issue 3, Pages (September 2015)
Toll-Like Receptor 5 Engagement Modulates Tumor Development and Growth in a Mouse Xenograft Model of Human Colon Cancer  Sang Hoon Rhee, Eunok Im, Charalabos.
Tetramethylpyrazine protects spinal cord and reduces inflammation in a rat model of spinal cord ischemia-reperfusion injury  Lihong Fan, MD, Kunzheng.
Volume 138, Issue 4, Pages e3 (April 2010)
Volume 137, Issue 4, Pages (October 2009)
Volume 79, Issue 9, Pages (May 2011)
Volume 135, Issue 4, Pages (October 2008)
Volume 132, Issue 7, Pages (June 2007)
Volume 141, Issue 4, Pages (October 2011)
Volume 139, Issue 1, Pages e6 (July 2010)
Volume 25, Issue 11, Pages (November 2017)
Volume 136, Issue 2, Pages (February 2009)
Volume 138, Issue 1, Pages (January 2010)
Covering the Cover Gastroenterology
Volume 141, Issue 1, Pages (July 2011)
A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice  Tohru Funakoshi, Kenichiro Yamashita, Nobuki.
Volume 141, Issue 1, Pages e1 (July 2011)
Volume 134, Issue 2, Pages e3 (February 2008)
Volume 142, Issue 4, Pages e2 (April 2012)
Volume 81, Issue 3, Pages (February 2012)
A Dual AP-1 and SMAD Decoy ODN Suppresses Tissue Fibrosis and Scarring in Mice  Hong-Feng Yuan, Hong Huang, Xiang-Yun Li, Wei Guo, Wei Xing, Zhi-Ya Sun,
Volume 84, Issue 2, Pages (August 2013)
Volume 134, Issue 1, Pages (January 2008)
Qinglan Zhao, Yi Wei, Stephen J. Pandol, Lingyin Li, Aida Habtezion 
IL-6 Secreted from Cancer-Associated Fibroblasts Mediates Chemoresistance in NSCLC by Increasing Epithelial-Mesenchymal Transition Signaling  Yasushi.
Volume 129, Issue 2, Pages (August 2005)
Volume 132, Issue 5, Pages (May 2007)
Volume 131, Issue 6, Pages (December 2006)
Antigen-Presenting Cell Production of IL-10 Inhibits T-Helper 1 and 17 Cell Responses and Suppresses Colitis in Mice  Bo Liu, Susan L. Tonkonogy, R. Balfour.
Volume 122, Issue 2, Pages (February 2002)
Volume 120, Issue 2, Pages (February 2001)
Volume 84, Issue 3, Pages (September 2013)
Volume 137, Issue 4, Pages (October 2009)
Volume 85, Issue 4, Pages (April 2014)
Chadrick E. Denlinger, MD, Brian K. Rundall, DO, Michael D
Volume 78, Issue 7, Pages (October 2010)
Volume 88, Issue 6, Pages (December 2015)
Syed M. Meeran, Thejass Punathil, Santosh K. Katiyar 
Volume 88, Issue 6, Pages (December 2015)
Digesting New Information About the Role of Trypsin in Pancreatitis
Presentation transcript:

Volume 144, Issue 1, Pages 202-210 (January 2013) Activation of Nuclear Factor-κB in Acinar Cells Increases the Severity of Pancreatitis in Mice  Haojie Huang, Yan Liu, Jaroslaw Daniluk, Sebastian Gaiser, Jun Chu, Huamin Wang, Zhao–Shen Li, Craig D. Logsdon, Baoan Ji  Gastroenterology  Volume 144, Issue 1, Pages 202-210 (January 2013) DOI: 10.1053/j.gastro.2012.09.059 Copyright © 2013 AGA Institute Terms and Conditions

Figure 1 Transgenic expression of p65 led to a compensatory response. (A) Pancreatic p65 expression increased after conditional transgenic mice (LSL-p65) were crossed with mice harboring pancreatic Ela-CreERT (LSL-p65/Cre, 3 days after last TM induction). NF-κB inhibitory subunit IκB-α was up-regulated in LSL-p65/Cre mice. (B) No obvious phenotypic changes in the pancreata of LSL-p65/Cre mice were observed (3 days after last TM induction). GAPDH, glyceraldehyde-3-phosphate dehydrogenase. Gastroenterology 2013 144, 202-210DOI: (10.1053/j.gastro.2012.09.059) Copyright © 2013 AGA Institute Terms and Conditions

Figure 2 High-dose cerulein caused enhanced NF-κB activity and increased severity of pancreatitis in mice with high basal p65 expression. (A) In an electrophoretic mobility shift assay, no NF-κB DNA binding changes were observed in the pancreata of control and LSL-p65/Cre (p65) mice. One hour after cerulein (50 μg/kg intraperitoneally) treatment, NF-κB DNA binding activity was increased in control mice (Control+Cerulein) and further up-regulated in LSL-p65/Cre mice (p65+Cerulein). (B) Real-time reverse-transcription polymerase chain reaction revealed that cytokines IL-1β, IL-6, and tumor necrosis factor (TNF)-α dramatically increased in the pancreas of mice with transgenic p65 expression (p65) compared with control mice 1 hour after a single dose of cerulein administration (50 μg/kg intraperitoneally). (C) Pancreata were removed 1 hour after 12 hourly repeated cerulein treatments (50 ug/kg intraperitoneally). More severe pancreatic damage was observed in Ela-CreERT × LSL-p65 mice with transgenic p65 overexpression (p65+Cerulein) than controls (Control+Cerulein). Gastroenterology 2013 144, 202-210DOI: (10.1053/j.gastro.2012.09.059) Copyright © 2013 AGA Institute Terms and Conditions

Figure 3 Cerulein treatment increased the severity of pancreatitis parameters. (A) After 12 repeated cerulein treatments, serum amylase level (OD, optical density) was higher in Ela-CreERT × LSL-p65 mice with pancreatic expression of p65 (p65+Cerulein). (B) Water content of the pancreata with high basal p65 expression was much higher. (C) In pancreata with transgenic expression of p65 (p65+Cerulein), there was more CD45 inflammatory cell infiltration (*P < .05 vs control, #P < .05 vs control+cerulein). IHC, immunohistochemistry. Gastroenterology 2013 144, 202-210DOI: (10.1053/j.gastro.2012.09.059) Copyright © 2013 AGA Institute Terms and Conditions

Figure 4 Repeated cerulein treatment causes chronic pancreatitis in mice with high basal p65 expression. (A) Control mice and Ela-CreERT × LSL-p65 mice were treated with 5 hourly intraperitoneal injections of cerulein (50 ug/kg), once a week for 5 consecutive weeks. Pancreata were harvested 2 weeks after the last injection. (B, C) Pancreata of control mice (control+cerulein) showed no obvious damages whereas focal chronic lesions were observed in most (5 of 6) of the Ela-CreERT × LSL-p65 mice (p65+cerulein). Gastroenterology 2013 144, 202-210DOI: (10.1053/j.gastro.2012.09.059) Copyright © 2013 AGA Institute Terms and Conditions

Figure 5 Acinar-specific expression of constitutively active IKK2 led to NF-κB p65 nuclear translocation and pancreatitis. (A) Immunohistochemical staining with antibody against p65 did not detect p65 nuclear translocation in control mice. (B) Transgenic p65 expression in Ela-CreERT × LSL-p65 (LSL-p65/Cre) mice led to higher basal p65 level (brown) without nuclear translocation (arrow). (C) Pancreatic-specific expression of constitutively active IKK2 in Ela-CreERT × LSL-IKK2 (LSL-IKK2/Cre) mice caused p65 nuclear translocation (arrow). (D) Pancreatic acinar damage and inflammatory cell infiltration were obvious 7 days after TM induction of IKK2 expression. (E) Pancreatic acinar damage, inflammatory cell infiltration, and fibrosis were evident 3 months after TM induction of IKK2 expression. (F) Co-expression of IKK2 and p65 further increased the severity of pancreatitis in Ela-CreERT × LSL-IKK2 × LSL-p65 (LSL-IKK2/LSL-p65/Cre) mice (7 days after TM). IHC, immunohistochemistry. Gastroenterology 2013 144, 202-210DOI: (10.1053/j.gastro.2012.09.059) Copyright © 2013 AGA Institute Terms and Conditions

Figure 6 Pancreatic-specific expression of active IKK2 or combination of active IKK2 and p65 increased pancreatitis parameters. (A) Pancreata from control mice (Control), (B) pancreata from Ela-CreERT × LSL-IKK2 mice with pancreatic acinar-specific expression of IKK2 (IKK), and (C) pancreata from Ela-CreERT × LSL-IKK2 × LSL-p65 mice with pancreatic acinar-specific expression of both IKK2 and p65 (IKK/p65) were stained with CD45 antibody by immunohistochemistry (7 days after TM). (D) Semiquantitative pathologic score evaluation including edema, inflammatory cell infiltration, and cell death were compared. Note that normal tissues were assigned a total score of 3. Gastroenterology 2013 144, 202-210DOI: (10.1053/j.gastro.2012.09.059) Copyright © 2013 AGA Institute Terms and Conditions

Figure 7 Increased NF-κB led to increased messenger RNA expression of cytokines and profibrogenic factors. (A) Transforming growth factor (TGF)-β, (B) IL-1β, (C) fibronectin, and (D) α-smooth muscle actin (α-SMA) were up-regulated in the pancreata of mice expressing IKK2 (IKK) or in combination of IKK2 and p65 (IKK/p65), but not in control mice (control) and mice expressing p65 (p65) 3 days and 9 days after the last TM induction. Gastroenterology 2013 144, 202-210DOI: (10.1053/j.gastro.2012.09.059) Copyright © 2013 AGA Institute Terms and Conditions